hrr

ThrRS-IN-2 is an inhibitor of threonyl-tRNA synthetase (ThrRS), exhibiting an inhibition concentration (IC50) value of 56.5 ± 3.5 μM.

ThrRS-IN-1 (Compound 30d) is a potent inhibitor of threonyl-tRNA synthetase (ThrRS) from Salmonella enterica (Se ThrRS), exhibiting an IC50 of 1.4 μM and a Kd of 1.36 μM. It uniquely targets both the tRNA Thr and L-threonine binding sites of ThrRS, demonstrating significant antibacterial activities [1].

ThrRS-IN-3, a threonyl-tRNA synthetase (ThrRS) inhibitor, exhibits high potency, demonstrated by an IC50 of 19 nM and a Kd of 34 nM against Salmonella enterica ThrRS. It also possesses antibacterial activities.

AZD-9574 is a selective inhibitor of PARP1 at the sites of SSBs. AZD-9574 exhibits anti-cancer activities and can be used in studies about HRD+ breast cancer and advanced solid malignancies.

NSAH (2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide) is a nonnucleoside inhibitor of human ribonucleotide reductase (hRR).with cell-free IC50 of 32 μM and cell-based IC50 of ~250 nM, respectively.